$BRZH
Breeze Holdings Acquisition Corp.

2022 Q1 Form 10-K Financial Statement

#000156459022009867 Filed on March 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $985.1K $451.8K $1.722M
YoY Change 347.06% 32.87% 406.58%
Operating Profit -$985.1K -$1.722M
YoY Change 347.06%
Interest Expense $52.88K $17.04K $47.84K
YoY Change 10962.76% 70.4% 378.4%
% of Operating Profit
Other Income/Expense, Net $3.553M $1.747M $10.38M
YoY Change -40.75% 17367.5% -571.75%
Pretax Income $2.568M $1.312M $8.704M
YoY Change -55.55% -497.58% -2737.57%
Income Tax
% Of Pretax Income
Net Earnings $2.568M $1.312M $8.704M
YoY Change -55.55% -497.58% -2737.57%
Net Earnings / Revenue
Basic Earnings Per Share $0.18 $0.59
Diluted Earnings Per Share $175.4K $89.62K $594.9K
COMMON SHARES
Basic Shares Outstanding 14.64M 14.63M
Diluted Shares Outstanding 14.64M 14.63M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.640K $5.400K $5.400K
YoY Change -97.21% -99.23% -99.23%
Cash & Equivalents $9.642K $5.403K
Short-Term Investments
Other Short-Term Assets $101.6K $124.2K $124.2K
YoY Change -59.59% 24.16% 24.16%
Inventory
Prepaid Expenses $124.2K
Receivables
Other Receivables
Total Short-Term Assets $111.3K $129.6K $129.6K
YoY Change -81.37% -84.4% -83.81%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $119.1M $117.9M $117.9M
YoY Change 2.04% 1.06% 1.06%
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $119.1M $117.9M $117.9M
YoY Change 2.04% 1.01% 0.97%
TOTAL ASSETS
Total Short-Term Assets $111.3K $129.6K $129.6K
Total Long-Term Assets $119.1M $117.9M $117.9M
Total Assets $119.2M $118.1M $118.1M
YoY Change 1.62% 0.4% 0.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.258M $598.5K $598.5K
YoY Change 3210.21% 498.45% 498.45%
Accrued Expenses $249.3K $200.0K $200.0K
YoY Change 405.52%
Deferred Revenue
YoY Change
Short-Term Debt $281.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $1.198M
YoY Change 775.01%
Total Short-Term Liabilities $4.114M $1.997M $1.997M
YoY Change 1824.29% 560.7% 898.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.609M $7.109M $7.109M
YoY Change -68.65%
Total Long-Term Liabilities $3.609M $7.109M $7.109M
YoY Change -68.65% 30419.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.114M $1.997M $1.997M
Total Long-Term Liabilities $3.609M $7.109M $7.109M
Total Liabilities $7.722M $9.105M $9.105M
YoY Change -34.13% -48.88% 2935.09%
SHAREHOLDERS EQUITY
Retained Earnings -$8.919M
YoY Change -47.38%
Common Stock $315.00
YoY Change 0.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.501M -$8.919M $109.0M
YoY Change
Total Liabilities & Shareholders Equity $119.2M $118.1M $118.1M
YoY Change 1.62% 0.4% 0.39%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income $2.568M $1.312M $8.704M
YoY Change -55.55% -497.58% -2737.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$276.8K -$4.190K -$688.4K
YoY Change -20.46% -98.32% 175.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.150M -$1.150M -$1.150M
YoY Change -99.01% -99.01%
Cash From Investing Activities -$1.150M -$1.150M -$1.150M
YoY Change -99.01% -99.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.431M 1.150M 1.150M
YoY Change -99.02% -99.02%
NET CHANGE
Cash From Operating Activities -276.8K -4.190K -688.4K
Cash From Investing Activities -1.150M -1.150M -1.150M
Cash From Financing Activities 1.431M 1.150M 1.150M
Net Change In Cash 4.239K -4.190K -688.4K
YoY Change -101.22% -100.61% -199.77%
FREE CASH FLOW
Cash From Operating Activities -$276.8K -$4.190K -$688.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70259
CY2021 brez Warrants Redemption Covenant Threshold Consecutive Trading Days
WarrantsRedemptionCovenantThresholdConsecutiveTradingDays
P30D
CY2021 brez Number Of Business Days Before Sending Notice Of Redemption Period
NumberOfBusinessDaysBeforeSendingNoticeOfRedemptionPeriod
P3D
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14640000
CY2021 brez Minimum Number Of Business Days To Redeem Public Shares
MinimumNumberOfBusinessDaysToRedeemPublicShares
P10D
CY2021 brez Warrants Redemption Covenant Threshold Trading Days
WarrantsRedemptionCovenantThresholdTradingDays
P20D
CY2021 brez Number Of Trading Days Prior On Consummates Business Combination
NumberOfTradingDaysPriorOnConsummatesBusinessCombination
P20D
CY2021Q4 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05
CY2021Q4 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05
CY2021 dei Auditor Name
AuditorName
Marcum LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2021Q4 us-gaap Cash
Cash
5403
CY2020Q4 us-gaap Cash
Cash
693818
CY2021Q4 us-gaap Assets Current
AssetsCurrent
129560
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity File Number
EntityFileNumber
001-39718
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1849315
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
955 W. John Carpenter Fwy.
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100-929
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Irving
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75039
CY2021 dei City Area Code
CityAreaCode
619
CY2021 dei Local Phone Number
LocalPhoneNumber
500-7747
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 dei Entity Public Float
EntityPublicFloat
115345000
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
117931556
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
23292
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
200000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
23156
CY2020Q4 brez Common Stock Payable
CommonStockPayable
74850
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
136949
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
302219
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
17487000
CY2020Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
23292
CY2021Q4 us-gaap Liabilities
Liabilities
9105262
CY2020Q4 us-gaap Liabilities
Liabilities
17812511
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
115000000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
115000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3125000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3125000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
315
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
313
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
475848
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6520309
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15224285
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6044146
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-15223972
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118061116
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117588539
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
344223
us-gaap Operating Income Loss
OperatingIncomeLoss
-344223
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
764
us-gaap Investment Income Interest
InvestmentIncomeInterest
178
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
9480
brez Expensed Offering Cost
ExpensedOfferingCost
395625
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1807500
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14631082
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4650246
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.59
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
325500
brez Adjustments To Additional Paid In Capital Allocation Of Ipo Proceeds To Rights Net Of Offering Costs
AdjustmentsToAdditionalPaidInCapitalAllocationOfIPOProceedsToRightsNetOfOfferingCosts
4214968
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
18499250
us-gaap Net Income Loss
NetIncomeLoss
-2537690
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6044146
CY2021 us-gaap Profit Loss
ProfitLoss
8703976
us-gaap Profit Loss
ProfitLoss
-2537690
brez Expensed Offering Costs On Issuance Of Warrants
ExpensedOfferingCostsOnIssuanceOfWarrants
395625
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
47076
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
9480
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1807500
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
401000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-36084
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-111926
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
531183
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
67264
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
176844
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
23156
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-688415
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-253625
CY2021 us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
1150000
us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
116725000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1150000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116725000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
brez Proceeds From Sale Of Units Net Of Underwriting Discounts Paid
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
112700000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5425000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1150000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
145617
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
145617
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
477557
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1150000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-688415
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
693818
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
693818
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5403
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
693818
CY2021 brez Compensation Expense For Common Stock Purchased By Directors From Sponsor
CompensationExpenseForCommonStockPurchasedByDirectorsFromSponsor
401000
CY2021 us-gaap Stock Issued1
StockIssued1
74850
brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
18499250
brez Value Of Common Stock Subject To Redemption
ValueOfCommonStockSubjectToRedemption
115000000
brez Initial Classification Of Warrant Liabilities
InitialClassificationOfWarrantLiabilities
15679500
brez Offering Costs In Exchange For Common Stock
OfferingCostsInExchangeForCommonStock
25000
brez Fair Value Of Public Rights Issued To Investors Net Of Offering Costs
FairValueOfPublicRightsIssuedToInvestorsNetOfOfferingCosts
4214968
brez Fair Value Of Representative And Consultants Shares
FairValueOfRepresentativeAndConsultantsShares
1322350
CY2021Q4 us-gaap Cash
Cash
5403
CY2020Q4 brez Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
5425000
CY2020Q4 brez Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
1.00
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4099907
CY2020Q4 brez Underwriting Fees
UnderwritingFees
2300000
CY2020Q4 brez Other Offering Costs
OtherOfferingCosts
477557
CY2021Q4 brez Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account
AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount
0.80
CY2021 brez Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination
MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination
0.50
CY2021Q4 brez Business Combination Minimum Threshold Limit Of Net Intangible Assets Required
BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired
5000001
CY2021 brez Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination
RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination
0.10
CY2021 brez Business Combination Incomplete Percentage Of Stock Redemption
BusinessCombinationIncompletePercentageOfStockRedemption
1
CY2021 brez Business Combination Completion Date Of Acquisition
BusinessCombinationCompletionDateOfAcquisition
2022-05-25
CY2021Q4 brez Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
100000
CY2021 brez Assets Remaining Available For Distribution Per Share Maximum
AssetsRemainingAvailableForDistributionPerShareMaximum
10.35
CY2021Q4 us-gaap Cash
Cash
5403
CY2021Q4 brez Working Capital
WorkingCapital
1667202
CY2020Q4 brez Proceeds From Sale Of Founder Shares
ProceedsFromSaleOfFounderShares
25000
CY2020Q4 brez Proceeds From Unsecured And Non Interest Bearing Promissory Note
ProceedsFromUnsecuredAndNonInterestBearingPromissoryNote
300000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </p>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2021 brez Offering Costs Incurred In Connection With Issuance Of Common Stock
OfferingCostsIncurredInConnectionWithIssuanceOfCommonStock
3704282
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
us-gaap Net Income Loss
NetIncomeLoss
-2537690
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14631082
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4650246
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.59
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of credit risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporate coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </p>
CY2021 us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000
CY2021 brez Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering
PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering
0.0275
CY2021 brez Cash Fee For Advisory Services Upon Consummation Of Business Combination
CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination
3162500
CY2021Q4 brez Number Of Fractional Shares Issued Upon Exercise Of Public Warrant
NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant
0
CY2021 brez Warrants Exercisable Period After Completion Of Business Combination
WarrantsExercisablePeriodAfterCompletionOfBusinessCombination
P30D
CY2021 brez Warrants Exercisable Period From Closing Of Initial Public Offering
WarrantsExercisablePeriodFromClosingOfInitialPublicOffering
P12M
CY2021 brez Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation
WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation
P5Y
CY2021Q4 brez Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
0
CY2021Q4 brez Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
CY2021 brez Minimum Period Of Prior Written Notice Of Redemption Of Warrants
MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants
P30D
CY2021Q4 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18.00
CY2021Q4 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.20
CY2021Q4 brez Minimum Percentage Of Equity Proceeds From Issuances
MinimumPercentageOfEquityProceedsFromIssuances
0.60
CY2021Q4 brez Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.15
CY2021Q4 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18.00
CY2021 brez Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.80
CY2021 brez Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination
WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination
P30D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5425000
CY2021Q4 brez Warrant Price Per Share
WarrantPricePerShare
1.00
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5425000
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1807500
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of common stock are entitled to one vote for each share.
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3125000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3125000
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36963
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
72287
CY2021Q4 brez Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
302805
CY2021Q4 brez Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
2107
CY2020Q4 brez Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
2028
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
337661
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70259
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
337661
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-267403
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-70259
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
267403
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
70259
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
152535
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
23479
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
337661
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
70259
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 brez Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities
-0.250
CY2020 brez Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities
-0.150
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.010
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.033
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.030
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.028
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
17487000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
10378500
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7108500

Files In Submission

Name View Source Status
0001564590-22-009867-index-headers.html Edgar Link pending
0001564590-22-009867-index.html Edgar Link pending
0001564590-22-009867.txt Edgar Link pending
0001564590-22-009867-xbrl.zip Edgar Link pending
brez-10k_20211231.htm Edgar Link pending
brez-10k_20211231_htm.xml Edgar Link completed
brez-20211231.xsd Edgar Link pending
brez-20211231_cal.xml Edgar Link unprocessable
brez-20211231_def.xml Edgar Link unprocessable
brez-20211231_lab.xml Edgar Link unprocessable
brez-20211231_pre.xml Edgar Link unprocessable
brez-ex311_6.htm Edgar Link pending
brez-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending